Adamis Pharmaceuticals (ADMP) Open to New Partnerships for EpiPen Alternative; Targets New NDA Submission by Year End - Bloomberg
- S&P 500 ends higher as markets weigh rising yields, upbeat corporate results
- Meta Platforms reports softer Q2 revenue guidance on plans to boost spending on AI
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- Equities mixed as investors eye earnings; yen on intervention watch
- ServiceNow (NOW) stock falls as refreshed subscription outlook trails estimates
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- Meta Platforms (META) Tops Q1 EPS by 39c, Offers Guidance
- Hasbro (HAS) brand strength sees earnings top expectations
- IBM (IBM) announces mixed Q1 results, HashiCorp acquisition; shares down
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
Generic EpiPen Pricing Parity and Less than 1% Share Supports $10 Adamis (ADMP) Target Price - Maxim Group
August 29, 2016 1:04 PM EDTAfter surging 25% on Friday as investors focused on the company's PFS an alternative to EpiPen, Adamis Pharmaceuticals (NASDAQ: ADMP) is down 15% Monday as Mylan (NYSE: MYL) announced the launch of a generic version for a list price of $300 per two-pack carton, a 50% saving.
Commenting on Adamis amid the news, Maxim Group analyst Jason Kolbert said price parity with existing generics at time of launch and modest... More
Adamis Pharmaceuticals (ADMP) Gains Despite Mylan's Generic EpiPen
August 29, 2016 7:57 AM EDTAdamis Pharmaceuticals (NASDAQ: ADMP) is gaining again despite news that Mylan (NYSE: MYL)... More
Adamis Pharmaceuticals (ADMP) Ramps to Session Highs on Volume
August 26, 2016 1:33 PM EDTAdamis Pharmaceuticals (NASDAQ: ADMP) pushes to the highs of the session on volume that is running 28x normal. Shares are up 19%.
... More